CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Northwestern University
Northwestern University
Oslo University Hospital
Wake Forest University Health Sciences
Benaroya Research Institute
Masonic Cancer Center, University of Minnesota
Northwestern University
University of Miami
Vejle Hospital
University of Southern California
Seoul National University Bundang Hospital
Vejle Hospital
Royal Marsden NHS Foundation Trust